Pharma Innovation Tech Congress 2021
Share
Now
WHY SHOULD YOU ATTEND?
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
Event Speakers
SANJAY GOHIL
Futures.health (UK)
NITIN DHAVATE
Novartis
NITIN DHAVATE
Novartis
NITIN DHAVATE, Country Head - Data Privacy (India, South Asia, Sub-Saharan Africa), Novartis
JON LEE-DAVEY
Vodafone (UK)
LALIT RAUTE
Johnson & Johnson
LALIT RAUTE
Johnson & Johnson
LALIT RAUTE, Regional Senior Manager - Market Access, Johnson & Johnson
DEBASHISH ROY
Pfizer
SARANG PANDE
Dr. Reddy’s Laboratories
SARANG PANDE
Dr. Reddy’s Laboratories
SARANG PANDE, Business Engagement Manager - Manufacturing, Systems, Dr. Reddy’s Laboratories
MYLES FURNACE
Ipsen (UK)
MYLES FURNACE
Ipsen (UK)
MYLES FURNACE, Real World Evidence Director Global Medical, Affairs, Ipsen (UK)
KAVITA LAMROR
Sanofi
KAVITA LAMROR
Sanofi
KAVITA LAMROR, Director, Real World Investigator, Digital Function, Sanofi
Bloomberg School of Public Health, and has an experience spanning >15 years in healthcare. She has global experience across markets in the bio-pharma and devices sector, which enable her to develop Value Evidence strategies across the drug development life cycle for successful market access.
In her current role, she is responsible for driving the RWE efforts for Sanofi’s cardiovascular portfolio. This includes the spectrum of activities from data gap identification & validation with global teams, identifying the right approach & RWD for generating RWE, implementation of the correct analytical approach, and dissemination of results to internal stakeholders & regulatory authorities.
Over the span of her career, Dr. Lamror has been involved in designing and concluding studies from epidemiology, clinical, HEOR, and commercial perspectives. Having worked on patient-level and summary level data, she has enabled evidence generation across multiple therapy areas, within Genmed as well asRare/Orphan drugs & diseases portfolios. As a part of evolving organizations, she has conceptualized and enabled the creation of custom tools and platforms for internal scientific discussions and for payer discussions.
Prior to joining Sanofi, Dr. Lamror has established revenue generating business units at 3 KPOs, where she was responsible for leading the Value Evidence unit (RWE, HEOR modelling & HEOR writing) as a subject matter expert. She pioneered novel analytics in her stint at Novartis. Her roles have a strong element of prioritizing, and consolidating data to identify, elicit and communicate the incremental value of health interventions, and seamlessly aligning the Dr. Kavita Lamror is a certified clinician with distinction, completed her MPH from Johns Hopkins same to the product value story. Having been a part of multiple executive leadership teams reporting to the board, she has been involved in creating value for organizations through organic growth, as well as through targeted acquisitions.
PRATHAMESH K
Merck KGaA
ASHUTOSH M
Biocon
ASHUTOSH M
Biocon
ASHUTOSH MITTAL, Head – Global Quality Digital & Program, Leader – Digital Transformation, Biocon
RAMINDERPAL S
Incubate.bio (UK)
ASHUTOSH I
Lupin
ASHUTOSH I
Lupin
ASHUTOSH INAMDAR, Senior General Manager - Strategy Cell, Lupin
Ashutosh Inamdar is an Electronics & Telecommunication graduate from Pune University, post which he completed his post-graduation from IIM Indore in 2009.
He heads Strategy for India business at Lupin Limited. He is responsible for conceptualizing, planning & executing strategic and novel initiatives. He has been pivotal in driving digital transformation, executing digital initiatives, devising alternative channels of engagement with major stakeholders, improving internal business processes and exploring potentials areas of growth. He is inculcating a culture of innovation & disruption in the business to make it future-ready and develop the next level of growth drivers.
He has 15 years of work experience spanning across multiple sectors like Telecom, IT, Manufacturing, Construction and Pharmaceutical. He has held leadership positions and played a significant role in driving growth focused initiatives & exploring new businesses during his tenure at Mahindra & Mahindra, Gammon India and Verizon India.
He is a squash player, sports fanatic, loves travelling & passionate about wildlife photography.
He is active on LinkedIn (www.linkedin.com/in/ashutoshinamdar) & his twitter handle is @ashutoshinamdar.
NEHA GUPTA
Ipsen (UK)
NEHA GUPTA
Ipsen (UK)
NEHA GUPTA, Senior Digital Product Owner Strategy and, Transformation, Ipsen (UK)
NAGENDRA K S
Dr. Reddy’s Laboratories
NAGENDRA K S
Dr. Reddy’s Laboratories
NAGENDRA KRISHNA SINGH, Associate Director - PD & Tech Transfer, Dr. Reddy’s Laboratories
BIJENDER K M
Alkem Laboratories
BIJENDER K M
Alkem Laboratories
BIJENDER KUMAR MISHRA, Chief Information Security Officer, Alkem Laboratories
VISHVAJIT M K
Fresenius Kabi
VISHVAJIT M K
Fresenius Kabi
VISHVAJIT M KARANDIKAR, Business Unit (BU) Head -Parenteral Nutrition, Fresenius Kabi
Educational Qualification:
• Science Graduate from Fergusson College - Pune (with distinction)
• Completed Management studies from Pune University - Pune (with distinction)
• Completed Management Executive Education Program from Mt Eliza - Melbourne, Australia
Extracurricular activities:
• Cricket (College team captain)
• Soft ball (West Zone)
1) E Merck India Ltd (Pharmaceutical Sales)
2) Worked as Business Manager in Congo – Central Africa
3) Fresenius Kabi India Pvt Ltd (Speciality Division)
• Successfully launched Parenteral Nutrition in 1995 .
• Achieved leadership position in hospital segment
• Created Nutrition Advisory Board and organized expert meeting with top Nutritionists in the Zone
• Exhibited strong leadership in Enteral Nutrition business
• Established Diabetes specific nutrition, High Protein formula as a new segment in supportive care;
• Actively participated “UCNtrial (United for Clinical Nutrition) “this is a multicentric, multinational trial
• Attended ESPEN LLL course (European Society for Parenteral and Enteral Nutrition, Life Long Learning course)
• Member of FRANC Asia Program (Fresenius Advanced Nutrition Course) with top international speakers
• Attended PENSA conference, Parenteral and Enteral Nutrition Society of Asia conference
• Conducted webinars and seminars with ISCCM – Indian Society for Critical Care Medicine
• Conducted numerous symposia with Indian Surgical Society, IASG, Indian Association of Surgical Gastroenterologists) , Oncologists etc
• Participated in meetings with national IDA (Indian Dietetics Association)
• Currently working as Business Unit Head ,Parenteral Nutrition Division at Fresenius Kabi
SIDDHI TRIVEDI
Beyond Identity (UK)
“AI, IoT, Blockchain, Big Data & Digitalisation for Pharma”
Event Schedule
Meet and to network with your conference colleagues.
09:30 - Welcome Address & Virtual Conference Platform Instructions
TEXT ANALYTICS AND INDUSTRY 4.0
09:40 – Improving Consumer Experience for Medical Information using Text Analytics
• A strong business need to efficiently consolidate customer feedback from HCP, Patients, etc.
• Unstructured data in form of medical / customer inquiry data
• Significant time and effort is spent in manually tagging / classifying data
• Leveraging Advanced & Text Analytics to better equip medical information teams
PRATHAMESH KARMALKAR, Principal Data Scientist - Text Analytics, Merck KGaA
10:10 – Industry 4.0 application in Pharma Manufactucturing arena
ADITYA KHADILKAR, Program Lead - Digital Transformation, Dr. Reddy’s Laboratories
10:40 – Morning Coffee/Tea & Discussion
CHALLENGES & OPPORTUNITIES
11:00 – DISCUSSION WITH EXPERTS: AI & IoT – Challenges, Opportunities and Implementation
• How is AI resolving the tech problems faced by the industry? How will the near future be?
• How is AI being put to utilize in the battle against the epidemic?
• Application of AI to clinical trial and Real-World Data - Blurring the boundaries
• How can AI change the Pharma industry?
• Challenges in AI, especially a lack of data integration and access of data?
• Major threats and challenges of drug discovery by AI
• Huge data delivered by IoT devices, how are they to be handled – data secured?
• Remote Patient monitoring via IoT made simpler
• What’s instore for us with this AI & IoT for this era?
Moderator:
VINAY WANDREKAR, Business Information Security Expert, Novartis
Panellists:
MANU GUPTA, Vice President – Information Technology, Cadila
BIJENDER KUMAR MISHRA, Chief Information Security Officer, Alkem Laboratories
DHAVAL PANDYA, Corporate CIO, Piramal
VAIBHAV RAO, Asia Digital Client Partner, Pfizer
JON LEE-DAVEY, Global IoT Healthcare Lead, Vodafone (UK)
RAMINDERPAL SINGH, Founder, Incubate.bio (UK)
ASHUTOSH INAMDAR, Senior General Manager Strategy, Lupin
12:10 – Patient recruitment using AI for clinical trials & How can AI change the Pharma industry
• How AI can improve clinical trials
• How does future looks like
• How AI is changing the Pharma industry
VARUN CHUGH, Director Technology Transformation, Novartis
12:40 - Networking luncheon
SMART LABS & LABORATORY
13:30 – We have reached a tipping point in drug discovery. Start planning for fewer labs and more computers!
• Computational biology is producing insights comparable or sometimes better than wet lab approaches.
• This includes structural modelling, quasi-mechanistic modelling, predictive (AI/ML) algorithms, and even causal inferences.
• Several large Pharma companies and start-ups have responded and are significantly investing in modeling-first approaches.
• However, in the next 2-3 years modelling-first approaches will become a critical requirement of the workflow, for scientists to remain competitive.
• This talk discusses the above points from both technology and industry perspectives, and proposes that the adoption chasm has already been crossed.
RAMINDERPAL SINGH, Founder, Incubate.bio (UK)
BLOCKCHAIN AND BIG DATA
14:00 – DISCUSSION WITH EXPERTS: Blockchain and Big Data in Pharma industry 4.0
• Challenges like data inconsistency, increasing customer expectation towards privacy, transparency, security and traceability?
• Implementation DO’s and DON’T’s on Blockchain products?
• How Blockchain helps to decrease the number of Pharma frauds?
• Blockchain growth in the next 5 years?
• How Big data speeding up the drug discovery?
• In what way Big data give hands in strategic planning and smart decision-making?
• What are preferable solutions for data integration and storage, data quality, security and privacy of data?
Moderator:
SIDDHI TRIVEDI, Founder, Beyond Identity (UK)
Panellists:
RASHMI HEGDE, Vice President Medical, Cipla
HRISHIKESH NASHIKKAR, Associate Director Blockchain, Novartis
KISHAN BARCHHA, Co-Founder, EasyCups
SARANG PANDE, Business Engagement Manager- Manufacturing Systems, Dr. Reddy’s Laboratories
14:50 – Afternoon Tea/Coffee
DIGITALIZATION, RWE AND RWD
15:10 – DISCUSSION WITH EXPERTS: Significance of Digitalization in Pharma
• How is digital transformation impacting the Pharma Industries?
• How can your company prepare for this digital transformation wave?
• Challenges and opportunities in moving to digitalization?
• How patients are involved in digital age in Pharma industry? Is their information secured? What is to be done?
• Customized services by smart innovation like apps, smart watch etc.....
• Commercial model evolution using digital in branded generics markets
• Zero Trust with Layered Defense
Moderator:
SANJAY GOHIL, Director, Futures.health (UK)
Panellists:
NEHA MISHRA, Associate Director, Service Delivery, Novartis
NAGENDRA KRISHNA SINGH, Associate Director - PD & Tech Transfer, Dr. Reddy’s Laboratories
ANKEET BHAT, Chief Strategy Officer, MapmyIndia
NEHA GUPTA, Senior Digital Product Owner Strategy and, Transformation, Ipsen (UK)
DEBASHISH ROY, Head- Digital Innovation & Strategic Initiatives, Abbott
ASHUTOSH MITTAL, Head – Global Quality Digital & Program, Leader – Digital Transformation, Biocon
JEFF KIM, Life Sciences Business Consulting Executive, EPAM Systems (US)
16:10 – DISCUSSION WITH EXPERTS: RWD and RWE drive in Pharma
• How Pharma will handle complexity of data in RWD?
• Discussing how the RWE helps to get custom-made treatments and drug therapies for patients
• What helps us to have a better understanding about data quality and data privacy?
• RWE gives efficient and cost-effective clinical trials? How?
• What are complications will rise by inserting new data source? And it leads to breakup in data?
• Obtaining patient-centric using RWE
• What kind of changes needed to be place in RWE?
• Compelling with regulatory
• Market access for innovative medicines in emerging markets
Moderator:
VISHVAJIT M KARANDIKAR, Business Unit Head -Parenteral Nutrition, Fresenius Kabi
Panellists:
MYLES FURNACE, Real World Evidence Director Global Medical Affairs, Ipsen (UK)
KAVITHA SRINIVASULU, Head of Cyber Security & Data Privacy, GAVS Technologies
KAVITA LAMROR, Director, Real World Investigator, Sanofi
LALIT RAUTE, Regional Senior Manager - Market Access, Johnson & Johnson
NITIN DHAVATE, Country Head - Data Privacy (India, South Asia, Sub-Saharan Africa), Novartis
17:00 - End of conference
Share
Now
Event Sponsors & Partners
Virtue Insight
CONCEPTUALISED BY
Virtue Insight
CONCEPTUALISED BY
Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.
Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.
Testimonials
GAVS Technology Head of Cyber Security & Data Privacy
Bilcare Limited-GCS General Manager-Business Operations
Lupin General Manager Strategy Cell
Presentation
